Navigation Links
InVitria's Cellastim Delivers Superior Results in Mammalian Cell Culture
Date:9/25/2008

FORT COLLINS, Colo., Sept. 25 /PRNewswire/ -- Steve Pettit, Director of the company's Cell Culture Group, presented results of InVitria's (http://www.InVitria.com) Cellastim in mammalian cell culture at the 2008 BioProcess International Conference in Anaheim, California this week.

"Cellastim showed superior results compared to other sources of albumin and delivered an average of 50% improvement in productivity in CHO cell lines using variety of the leading chemically defined and animal free medias sold in the US," said Dr. Steve Pettit, Director of InVitria's Cell Culture Group.

Studies support InVitria's claim that its Cellastim product, an animal free recombinant human serum albumin, outperforms other chemically defined cell culture ingredients and is gaining acceptance by the biopharmaceutical industry as a supplement for cell culture media. Cellastim is a defined supplement that can enhance performance of chemically-defined media.

Additionally, InVitria's Lacromin product, which is an animal free recombinant lactoferrin, has proven to be a strong growth factor while simultaneously enhancing productivity across many cell lines.

"We continue to show powerful results of Cellastim and Lacromin in cell culture media for a variety of cell lines including CHO, Hybridoma, Vero and NS0 cells. Since these are well defined supplements, they help our customers achieve both their regulatory and manufacturing goals. These are the only supplements available that not only improve cell culture performance, but do this while maintaining a defined and animal free media," said Scott Deeter, InVitria's President.

To obtain a copy of Dr. Pettit's presentation please contact InVitria by phone or email at:
1-800-916-8311

info@InVitria.com

About InVitria (http://www.InVitria.com)

InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.
2. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
3. Core Informatics Delivers Enterprise Core LIMS Installation to BioRelix Pharmaceuticals
4. NIOXIN(R) Delivers the Future to Scalp and Hair Care, Introduces the First Genetic Test to Determine the Likelihood of Hair Loss
5. Millennium Over-Delivers on 2007 Goals and Financial Guidance
6. Nikon Instruments New NIS-Elements C Delivers Comprehensive Confocal and Widefield Imaging Capabilities in Single Unifying Software Platform
7. CompareNetworks Media Group Delivers CME/CE Through Acuity Medical Education
8. Superior Patient Clinical Outcomes Confirms DaVitas Leadership Position on Quality Dialysis Care
9. Increasing Sales Productivity Through Superior Sales Force Performance Management
10. By adding graphene, researchers create superior polymer
11. Flurizans Effect in Delaying Progression From Mild Cognitive Impairment to Alzheimers Disease is Superior to That of Aricept
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... CA (PRWEB) , ... January 21, 2017 , ... ... our ongoing endeavors to bring to market a pioneering medical device for the ... has signed an engagement contract with Emergo, a global regulatory consultancy that helps ...
(Date:1/21/2017)... Aratana Therapeutics, Inc. (NASDAQ: PETX ... development and commercialization of innovative biopharmaceutical products for companion ... North America 2016. ... on the FDA approval of three innovative therapeutics in ... (capromorelin oral solution) and NOCITA ® (bupivacaine liposome ...
(Date:1/20/2017)... -- Stock-Callers.com explores the Biotech industry to ... recent performances of select equities. In this morning,s lineup ... Abeona Therapeutics Inc. (NASDAQ: ABEO ), Theravance ... Therapeutics Inc. (NASDAQ: SAGE ). According to ... market size is expected to reach $604.40 billion by 2020 due to ...
(Date:1/20/2017)... MALDEN, MA (PRWEB) , ... ... ... the leader in Less Exposure Surgery (LES®) Technologies, announced today the next ... the PedFuse Pedicle Screw System platform). In contrast to the competition, SpineFrontier ...
Breaking Biology Technology:
(Date:1/18/2017)... , Jan. 18, 2017  In vitro diagnostic ... to mergers and acquisitions (M&A), and Kalorama Information expects ... such acquisitions have been shifting. Generally, uncertainty in reimbursement ... and the U.S. has changed the acquisitions landscape. Instead ... resulted in companies buying partners outside of their home ...
(Date:1/13/2017)... 13, 2017 Sandata Technologies, LLC, a ... homecare industry, including Electronic Visit Verification™ (EVV™), announced ... Jugs, as Senior Vice President of Product Management. ... of homecare experience to Sandata, where he will ... to align Sandata,s suite of solutions with the ...
(Date:1/12/2017)... Jan. 12, 2017  New research undertaken by Fit ... the future.  1,000 participants were simply asked which office technology ... we may consider standard issue.  Insights on what will ... also gathered from futurists and industry leaders including Penelope ... Canton .  Some of these findings ...
Breaking Biology News(10 mins):